The Legislature will return from Spring Recess on Monday, April 10. Policy committees will be in full swing as legislators work to get their bills heard before the Policy Committee deadline in May. Here is a glance at where CSAP’s sponsored and co-sponsored
More details have been released regarding the Administration’s plans to modernize the Mental Health Services Act (MHSA) and to seek bond funding to support behavioral health treatment capacity. The Administration is planning for a November 2024 ballot measure that will include
APA Submits Comments to the Drug Enforcement Administration (DEA) The APA has submitted comments to the DEA on the two proposed rules around telemedicine prescribing of controlled substances (Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior
SB 43 (Eggman) Advances in the Legislature CSAP’s co-sponsored SB 43 (Eggman), which proposes to rewrite California’s definition of grave disability, passed through the Senate Health Committee Wednesday afternoon on a 12-0 vote. CSAP Government Affairs Committee (GAC) member Aaron Meyer (SDPS) was one of
The Committee on Psychotherapy for the Group for the Advancement of Psychiatry (GAP), has sent a letter to Department of Managed Health Care Director Mary Watanabe voicing concerns with SB 855. Specifically, DMHC allowing health plans to force terminations of established therapeutic relationships
The CSAP Governmental Affairs Committee recommended to the Board, and the Board concurred on, the following positions with respect to new legislation. Oppose Unless Amended: AB 236 (Holden) Health care coverage: provider directoriesSeek the following amendments:(1) Remove the provision about removing a provider from
Paul Yoder of SYASL testified before the California Board of Pharmacy on March 15. This Board has a standing item on every agenda for the public to request that the Board agendize issues for subsequent meetings. After Paul’s testimony, one of the Board
